Skip to main content
J

Jinhe Biotechnology CO.,LTD. — Investor Relations & Filings

Ticker · 002688 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,825 across all filing types
Latest filing 2025-08-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002688

About Jinhe Biotechnology CO.,LTD.

https://www.jinhe.com.cn

Jinhe Biotechnology CO.,LTD. specializes in the research, development, and manufacturing of animal health products and feed additives. The company is a prominent global producer of chlortetracycline (CTC), maintaining extensive production capacity for feed-grade antibiotics. Its diverse product portfolio includes veterinary pharmaceuticals such as salinomycin and monensin, alongside a range of biological products and animal vaccines. Jinhe Biotechnology leverages advanced fermentation technology and integrated research capabilities to provide solutions for the livestock and poultry sectors. The company focuses on improving animal growth performance and disease prevention through standardized production processes and a global distribution network. Its operations span the development of specialized additives and the provision of comprehensive veterinary medical products designed to support large-scale animal husbandry.

Recent filings

Filing Released Lang Actions
简式权益变动报告书
Regulatory Filings
2025-08-19 Chinese
关于公司取得发明专利及外观设计专利证书的公告
Regulatory Filings
2025-08-12 Chinese
关于控股股东及一致行动人减持股份触及1%整数倍的公告
Regulatory Filings
2025-08-12 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings
2025-07-30 Chinese
2025年半年度报告摘要
Regulatory Filings
2025-07-30 Chinese
关于募集资金2025年半年度存放、管理与使用情况的公告
Regulatory Filings
2025-07-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.